Product Information

ROPINIROLE HCL 1 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.0461 per EA under NDC 69452035820. Its NADAC has been published 184 times since May 10, 2023.

FDA first approved this application on Nov 28, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROPINIROLE HCL 1 MG TABLET

Ropinirole
$0.0461per EA

Strength

1 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452035820

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ROPINIROLE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA079229

FDA Approved

11/28/2012

TE Code

AB

On Market Since

9/15/2022

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for ROPINIROLE HCL 1 MG TABLET has been published 184 times since May 10, 2023, and over the history we have for it it has declined 21.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0461 per EA
All-time high$0.0616 (Sep 11, 2024)
All-time low$0.0398 (Nov 20, 2024)
52-week high$0.0549
52-week low$0.0461
Median price$0.0536
Average price$0.0530
Largest weekly change-25.6% (Nov 20, 2024)
Weeks tracked184
Tracking sinceMay 10, 2023

Price History

1W

0.0%

1M

-3.4%

3M

-9.6%

6M

-11.7%

1Y

-12.6%

3Y

-16.2%

5Y

N/A

All

-21.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ropinirole market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ROPINIROLE HCL 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 1 MG TABLET, manufactured by Bionpharma Inc., is $0.0461 per EA (NDC 69452035820), effective Nov 11, 2026.

How has the price of ROPINIROLE HCL 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for ROPINIROLE HCL 1 MG TABLET has declined 21.9%. It has been tracked across 184 weekly CMS publications since May 10, 2023.

What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 1 MG TABLET?

Since May 10, 2023, the NADAC for ROPINIROLE HCL 1 MG TABLET has ranged from a low of $0.0398 (Nov 20, 2024) to a high of $0.0616 (Sep 11, 2024), with a median of $0.0536 per EA.

Are there cheaper alternatives to ROPINIROLE HCL 1 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ROPINIROLE HCL 1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ROPINIROLE HCL 1 MG TABLET?

ROPINIROLE HCL 1 MG TABLET (NDC 69452035820) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.